ENT, Ophthalmology & Skin Medicines/Medical Devices
key details
| Value | £14,040,297 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 +1 more |
| Region | Scotland |
| Deadline | 21 Apr 2020 |
| Procedure | open |
| OCID | ocds-r6ebe6-0000617625 |
Awards (33)
This procurement was awarded to 33 suppliers. Values shown are per-award; the notice total is £14,040,297.
description
This Framework Agreement is for the supply of ENT, Ophthalmology & Skin Medicines/Medical Devices to health boards across NHS Scotland.
The Goods have been split into two (2) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
documents
- ENT, Ophthalmology & Skin Medicines/Medical Devices , contractNotice
- ENT, Ophthalmology & Skin Medicines/Medical Devices , awardNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £22,471,323 · 6 Jan 2026
- Contrast Media Agents · £44,036,295 · 27 Jun 2024
- NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £35,467,873 · 7 Mar 2024
- NP811-17 Lift Maintenance Services · £5,750,000 · 19 Jul 2023
- Generic and Biosimilar Cancer Medicines · £33,350,281 · 21 Apr 2023
- NP36722 Fertility Products · £6,490,616 · 18 Jan 2023
- NP41422 Contraceptive Medicines · £7,369,432 · 8 Jul 2022
- NP39722f Lenalidomide · £4,300,000 · 7 Jun 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.